Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 5, 1998, Pages 298-302

  Herse, B ^a,c   Dalichau, H ^a   Wormann B ^a   Hemmerlein, B ^a   Schmidberger, H ^a   Hess, C F ^a   Hannemann, P ^b   Criee C P ^b   Hiddemann, W ^a   Griesinger, F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Lenglern Regional Hospital   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Advanced non small cell lung cancer; Carboplatin; Docetaxel; Induction chemotherapy; Surgery

Indexed keywords

CARBOPLATIN; DOCETAXEL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; TREATMENT OUTCOME;

EID: 7844236776     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1010242     Document Type: Article

References (20)

1. Shepard FA. Induction chemotherapy for locally advanced non-small-cell lung cancer. Ann Thorac Surg. 1995;55:1585-92.
2. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg. 1994;107:19-28.
3. Rusch VW. Resection of stage III non-small-cell lung cancer following induction therapy. World J Surg. 1995;19:817-22.
4. Ohta M, Tsuchiya R, Shimoyama M, et al. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer - results of a randomized prospective study. J Thorac Cardiovasc Surg. 1993;106:703-8.
5. Albain KS, Rusch VW, Crowly JW, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of South-West Oncology Group phase II study 8805. J Clin Oncol. 1995;13:1880-92.
6. Elias AD, Skarin AT, Leong T, et al. Neoadjuvant therapy for surgically staged IIIA N2 non-small-cell lung cancer (NSCLC). Lung Cancer. 1997;17:147-61.
7. Favaretto A, Paccagnella A, Tomio L, et al. Preoperative chemoradiotherapy in non-small-cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study. Eur J Cancer. 1996; 32 (Part A);2064-9.
8. Martini N, Kris MG, Fehinger BJ, et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg. 1993;55:1365-74.
9. Niell HB, Miller AA, Kumar P, Griffin JP, Mohyuddin AI. Phase I/II trial of paclitaxel (TAX), cisplatin (DDP) and radiation therapy for stage III non-small-cell lung cancer (NSCLC). Proc Annu Meet Am Soc Clin Oncol. 1996;15:A1173.
10. Skarin A, Jochelson M, Sheldon T, et al. Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small-cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol. 1989;40:266-74.
11. Vokes EE, Bitran JD, Hoffman PC, Ferguson MK, Weichselbaum RR, Golomb HM. Neoadjuvant vindesine, etoposide and cisplatin for locally advanced non-small-cell lung cancer - final report of a phase 2 study. Chest. 1989;96:110-3.
12. Weiden PL, Piantadosi S. Preoperative chemotherapy (cisplatin and fluouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the lung cancer study group. J Natl Cancer Inst. 1991;83:266-77.
13. Rosell R, Gómez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153-8.
14. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Canc Inst. 1994;86:673-80.
15. Harper P. The role of docetaxel (taxotere) as a single agent or in combination before local treatment of non-small-cell lung cancer. Semin Oncol. 1997;24 (4 Suppl 14):14-30.
16. Fischer JR, Manegold C, Bulzebruck H, Vogt-Moykopf I, Drings P. Induction chemotherapy with and without recombinant human granulocyte colony stimulating factor support in locally advanced stage III A/B non-small-cell lung cancer. Semin Oncol. 1994;21 (3 Suppl 4):20-7.
17. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol. 1995;13:1860-70.
18. Eberhardt W. Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB non-small-cell bronchial carcinoma. Schweiz Rundsch Med Prax. 1997;86:1647-53.
19. Thomas M, Rube C, Semik M, Junker K, von Eiff M. Neoadjuvante multimodale Therapie im Stadium IIIA des nicht-kleinzelligen Bronchialkarzinoms. Dtsch Med Wochenschr. 1997;122:993-8.
20. Francis PA, Rigas JR, Kris MG, et al. Phase II trial of docetaxel in patients with stage III and IV non-small-lung cell cancer. J Clin Oncol. 1994;12:1232-7.